404 LY2228820 Dimesylate, a P38 MAPK Inhibitor, Demonstrates Anti-Neoplastic Activity in Mouse Models of Human Ovarian Cancer

Autor: Pratt, S., Gilmour, R., Brooks, N., Chan, E., Stancato, L.
Zdroj: In European Journal of Cancer November 2012 48 Supplement 6:123-123
Databáze: ScienceDirect